Two hundred and fifty bone marrow and 140 lymph nodal biopsies were analyzed immunocytochemically, using a mouse monoclonal antibody b-12 (MAb b-12), which reacts with MCA (mucinous-like carcinoma-associated antigen). The presence of MCA in bone marrow specimens was demonstrated in 102 out of 105 (97.1%) breast cancer metastases, 5 out of 8 (62.5%) gastric cancers, 5 out of 6 (83.3%) colon cancers, 3 out of 5 (60%) prostate cancers, 11 out of 26 (42.3%) lung cancers and 25 out of 30 (83.3%) unknown primary cancers, while no positivity to anti-MCA antibody was found in 30 cases of normal bone marrow biopsies, 5 cases of non epithelial malignancies and 30 cases of hemolymphoproliferative disease. Normal lymph nodes and non-epithelial lymph node metastases did not show any reaction to MAb b-12; on the contrary MCA positive staining was observed in 75 out of 75 (100%) lymph nodal metastases in breast cancer. These results suggest that application of MAb b-12 in immunohistochemistry is valid for the detection of bone marrow and lymph nodal micrometastases of epithelial origin.
StähliC., TakacsB., MiggianoV.. Monoclonal antibodies against antigens on breast cancer cells.Experientia1985; 41: 1377–81.
2.
StahliC., CaravattiM., AeschbacherM.. A mucin-like carcinoma-associated antigen (MCA) defined by three monoclonal antibodies against different epitopes.Cancer Res1988; 48: 6799–802.
3.
Saccani JottiG., FontanesiM., ColomboA.. Localization of mucinous-like carcinoma-associated antigen (MCA) in breast pathology: comparison with carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA).Int J Biol Markers1990; 5: 145–52.
4.
ZenklusenH.R., StahliC., GudatF.. The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal neoplastic human tissues.Virchows Archiv A Pathol Anat1988; 413: 3–10.
5.
Saccani JottiG., BombardieriE.. Circulating tumor markers in breast cancer.Anticancer Res1990; 10: 253–8.
6.
BombardieriE., GionM., MioneR.. A mucinous like carcinoma associated antigen (MCA) in the tissue and in blood of patients with primary breast cancer.Cancer1989; 63: 490–5.
7.
BonadonnaG.. Conceptual and practical advances in the management of primary breast cancer. The Karnofsky Memorial Lecture.J Clin Oncol1989; 7: 1380–97.
8.
ReddingW.H., CoombesR.C., MonaghanP.. Detection of micrometastases in patients with primary breast cancer.Lancet1983; 1271–4.
9.
CoombesR.C., BergerU., MansiJ.. Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer.NCI Monogr1986; 1: 51–3.
10.
SloaneI.F., OrmerodM.G., NevilleA.M.. Potential pathological application of immunocytochemical methods to the detection of micrometastases.Cancer Res1980; 40: 3079–82.
11.
CoteAl, RosenP.P., HakesT.B.. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.Am J Surg Path1980; 12: 333–40.
12.
Mariani-CostantiniR., MénardS., ClementeC.. Immunocytochemical identification of breast carcinoma cells in effusions using a monoclonal antibody.J Clin Pathol1982; 35: 1037.
13.
MénardS., TagliabueE., CanevariS.. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.Cancer Res1983; 43: 1295–1300.
14.
TagliabueE., PorroG., BarbantiP.. Improvement of tumor cells detection using a pool of monoclonal antibodies.Hybridoma1986; 5: 107–15.
15.
NutiM., MottoleseM., VioraM.. Use of monoclonal antibodies to human breast-tumor-associated antigens in fine-needle aspirate cytologyInt J Cancer1986; 37: 493–8.
16.
SchlimokG., FunkeI., HolzmannB.. Micrometas-tatic cancer cells in bone marrow: in vitro detection with anti-cytocheratin and in vivo labeling with anti-17-1A monoclonal antibodies.Proc Natl Acad Sci USA1987; 84: 8672–6.
17.
PorroG., MénardS., TagliabueE.. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients.Cancer1988; 61: 2407–11.
18.
EllisG., FergusonM., YamanakaE.. Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients.Cancer1989; 63: 2509–14.
19.
MathieuM.C., FriedmanS., BosaJ.. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer.Breast Cancer Res Treat1990; 15: 21–6.
20.
HsuS.M., RaineL., FangerH.. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.Am J Clin Pathol1981; 75: 734–8.
21.
HsuS.M., RaineL., FangerH.. Use of avidin-peroxidase complex (ABC) in immunoperoxidase techniques.J Histochem Cytochem1981; 29: 577–80.
22.
MansiJ.L., BergerU., EastonD.. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.Br Med J1987; 295: 1093–6.
23.
UntchM., HarbeckN., EiermannW.. Micrometastases in bone marrow in patients with breast cancer.Br Med J1988; 290–6.
24.
ThorA., ViglioneM.J., OhuchiN.. Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow.Breast Cancer Res Treat1988; 11: 133–45.
25.
MansiJ.L., BergerU., McDonnellT.. The fate of bone marrow micrometastases in patients with primary breast cancer.J Clin Oncol1989; 7: 445–9.
26.
TrojaniM., De MascarelI., BonichonF.. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.Br J Cancer1987; 55: 303–6.
27.
NevilleA.M.. Prognostic factors and primary breast cancer.Diagn Oncol1990; 1: 53–63.
28.
NevilleA.M., BettelheimR., PriceK.N.. Occult axillary lymph node micrometastases from breast cancer are prognostically important.Lancet1990 (in press).
29.
SpringallA.L., RytinaE.R.C., MillisR.R.. Incidence and significance of micrometastases in axillary lymph nodes detected by immunohistochemical techniques.J Pathol, in press.
30.
EskelinenM., LipponenP., CollanY.. Immunohistochemical staining of human bladder cancer with a new tumor marker MCA: relation to histological grade (Q), clinical stage (UICC), and survival.Surg Res Comm1989; 7: 45–53.
31.
ThivoletT.. The role of MCA in dermatology: monoclonal antibodies in cutaneous immunohistochemistry.J Dermatol1986; 13: 313–25.
